Subscribe To
Sensei Biotherapeutics Appoints Stephanie Krebs, MS, MBA, as Chief Business Officer
BOSTON, Nov. 01, 2023 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced the appointment of Stephanie Krebs, MS, MBA, as Chief Business Officer. Ms. Krebs joins Sensei from SNIPR Biome, a clinical-stage biotechnology company where, as […] The post Sensei Biotherapeutics Appoints Stephanie Krebs, MS, MBA, as Chief Business Officer appe...
Read More
Posted: Nov 1 2023, 11:30
Author Name: forextv
Views: 112191